How to Buy Mannkind Stock
Mannkind Corp
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States.
Mannkind stock last closed at $5.94, up 0% from the previous day, and has decreased 5.26% in one year. It has overperformed other stocks in the Biotechnology industry by 0.37 percentage points. Mannkind stock is currently +75.69% from its 52-week low of $3.38, and -15.98% from its 52-week high of $7.07.
There are currently 307.07M shares of MNKD outstanding. The market cap of MNKD is $1.82B. In the last 24 hours, 2.91M MNKD shares were traded.
How to Buy Mannkind Stock
Not sure how to invest in Mannkind stock? Here's how.
- Decide where to buy Mannkind stock: You need to choose a stock brokerage, but don't worry - we've tested dozens of online brokerages and apps to help you choose where to buy Mannkind stock.
- Open a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
- Deposit money your brokerage account: Pick your payment method and add your details.
- Evaluate Mannkind stock: The Mannkind ticker symbol is MNKD. Is Mannkind stock a good investment? Should you buy shares of MNKD? How do MNKD's underlying business fundamentals look? Do top analysts think Mannkind is a good buy? Why has MNKD's stock price moved recently? (Hint: Our stock market analysis tools can help you decide if MNKD is a good stock to buy).
- Place your MNKD purchase: Decide if you will purchase MNKD shares at the current market price or use a limit order to purchase MNKD shares at a given price.
- Get the latest scoop on your MNKD position: Create a watchlist to important updates regarding your position in Mannkind stock.
Step 1: Decide where to buy Mannkind stock
You need a brokerage account in order to access the NASDAQ market and buy MNKD stock.
Our recommended brokerage: eToro
We believe that eToro is the best brokerage. eToro gives you:
- You can invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
- Access to global financial markets: From Tech to Financial Services, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading exchanges.
- Social investing: eToro offers a community with more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by opening an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Open a brokerage account
Now that you've selected the best brokerage, the next step is to fill out some personal details so you are able to invest in MNKD today.
How to Open a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal info to start a new trading account.
- Send your details by pressing the "Create Account" button. Get started with eToro today
Step 3: Deposit money your brokerage account
Now that you've opened your account on apps for stocks, you need to deposit funds:
Watch the walkthrough below to see the process of depositing money into your new investment account.
Step 4: Evaluate Mannkind stock
Once you have figured out the best place to buy Mannkind stock, it's very important to evaluate their stock prior to investing, so you actually understand the risk as well as the opportunity.
Overview of key MNKD info
MNKD Fundamentals
WallStreetZen was created to help average investors perform better fundamental analysis in minutes instead of hours.
You can view all of the due diligence checks on MNKD's stock page.
Is MNKD stock undervalued?
Investors use a variety of different financial metrics, analyses, models, and charts to gauge MNKD's fair value.
Using relative valuations methods:
- MNKD may be undervalued based on its P/E ratio of 59.4x, relative to Biotechnology industry P/E ratio of 148.94x
- MNKD could be overvalued based on its PEG ratio of 2.54x
You can do more valuation research on MNKD's stock here.
A quick look at MNKD Financials
Pros:
- MNKD profit margin has gone up from 8.1% to 9.3% in the past year.
- There are more short-term assets than short-term liabilities on the MNKD balance sheet.
Cons:
- MNKD earnings of $62.42M is not sufficient to cover its interest payments.
- There are more long-term liabilities than short-term assets on the MNKD balance sheet.
- MNKD debt to equity ratio of -12.1 is negative.
- MNKD's operating cash flow of $48.86M allows it to safely service it's debt of $360.39M.
- Total MNKD debt is still negative.
Is it a good time to buy Mannkind stock, according to analysts?
Out of 6 Wall Street analysts who give ratings on MNKD, the consensus analyst rating on Mannkind is a Strong Buy
Please keep in mind that analyst forecasts are not recommendations, nor are they investment advice.
Latest MNKD Analyst Forecasts
Tiago Fauth, a top 12% analyst from Wells Fargo maintains MNKD with a strong buy rating and raises their MNKD price target from $9.00 to $10.00, on Sep 3, 2025.
You can dig deeper into what analysts are saying on the Mannkind stock forecast page.
MNKD Momentum
Is MNKD Growing Revenue?
Last year, MNKD earnings were $29.23M. In the last one years, MNKD's earnings have grown by 25% per year. This was faster than the Biotechnology industry average of 10.91%.
Last year, MNKD revenue was $313.79M. In the last 5 year, MNKD's revenue has increased by 38% per year. This was slower than the Biotechnology industry average of 43.87%.
Dive into MNKD's earnings and revenue performance here.
What are MNKD executives and large shareholders up to?
Over the past year, executives and large shareholders at MNKD have sold more shares than they have bought.
Michael Castagna, Chief Executive Officer of MNKD, was the latest MNKD insider to buy. They bought $491,036.00 worth of MNKD shares on Dec 2, 2025.
Get more info about who owns MNKD stock here.
Does MNKD stock generate passive income?
No, Mannkind doesn't provide an income stream by paying out dividends.
Get analysis from other investors
One of the primary reasons eToro is our favorite brokerage is because of its social trading community.
Click below to see what other investors have to say.
Step 5: Place your MNKD purchase
You have two main order types:
- Market order: A market order is an order to buy or sell a security at the best possible price.
Market orders are generally the best for newer investors. - Limit order: A limit order lets you buy or sell a security at a specific price (or better).
If you want to ensure you're buying or selling at an exact price, place a limit order.
Click the Open Trade button and your broker will place your order.
If you need more help with buying stocks on eToro, watch the how to video below:
Step 6: Get the latest scoop on your MNKD position
Now that you own some shares in MNKD, you'll want to keep up with your investment.
Put MNKD on a watchlist to track your MNKD stock.
MNKD Feed
How to Buy Stock in Mannkind
To summarize, here are the 6 steps you need to take to buy Mannkind stock right now:
- Decide where to buy Mannkind stock
- Open a brokerage account
- Deposit money your brokerage account
- Evaluate Mannkind stock
- Place your MNKD purchase
- Get the latest scoop on your MNKD position
If you are looking for a brokerage, eToro is our favorite option.
Get Started with eToro TodayIf you would like to get notifications regarding your new investment in Mannkind, click the button below.
Related Articles
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.